|
O,O’-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-18 00:00:00 |
| Sponsor | NanoPharmaceuticals, LLC;1 Discovery Place;Rensselaer, New York, 12144 |
